Status:
COMPLETED
Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1
Lead Sponsor:
Université de Sherbrooke
Collaborating Sponsors:
Rare Disease Foundation
Conditions:
Myotonic Dystrophy 1
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
20 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exerci...
Eligibility Criteria
Inclusion
- DM1 diagnosis must be confirmed by genetic analysis;
- Women sex, aged between 30 and 65 years old;
- Be able to walk without assistance;
- Consent of the neurologist must be given to participate in this study;
- Must reside in the Saguenay-Lac-St-Jean region;
- Subjects must be able to give their consent freely and voluntarily.
Exclusion
- Patients with any other form of muscular dystrophy are excluded;
- Any contraindication for strenuous exercise or muscle biopsy.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2023
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05400629
Start Date
January 1 2022
End Date
January 10 2023
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
Saguenay, Quebec, Canada, G7X 7X2